India Biomaterials in Healthcare Market Report 2022 to 2030

India Biomaterials in Healthcare Market Analysis

$ 3999

The India Biomaterials Healthcare Market is expected to witness growth from $2.84 Bn in 2022 to $9.44 Bn in 2030 with a CAGR of 16.20% for the forecasted year 2022-2030. India's large and ageing population increases its susceptibility to serious illnesses including osteoarthritis and cardiovascular disease, which usually require the use of biomaterials as a therapy, leading to the growth of the country's biomaterial healthcare industry. The market is segmented by type and by application. Some key players in this market include Poly Medicure, Sahajanand Medical Technologies, MicroPort, BASF SE, Celanese, Covestro AG and Evonik Industries.

ID: IN10INMD003 CATEGORY: Medical Devices GEOGRAPHY: India AUTHOR: Jigyasu Bhandari

Buy Now

India Biomaterials in Healthcare Market Executive Analysis

The India Biomaterials Healthcare Market size is at around $2.84 Bn in 2022 and is projected to reach $9.44 Bn in 2030, exhibiting a CAGR of 16.20% during the forecast period. The Union Budget for 2023 in India includes a staggering $10.75 Bn for health expenses, an increase of $0.28 Bn or 2.71% from the $10.47 Bn in FY23. Budget estimates for the Ministry of Health for 2022–2023 were initially $10.42 billion but were later reduced to $9.57 billion for the same period. An estimated $10.78 billion will be invested this year. In India, healthcare expenditure is down to 1.97% from last year's 2.2% of the budget.

In orthopaedics, biomaterials are frequently used for fracture fixation, spine fusion, and joint replacement. Implants that can meld with bone tissue are made using biomaterials like metals, ceramics, and polymers. Cardiovascular devices like pacemakers and tubes are created using biomaterials. Materials that are biocompatible and able to endure the stresses placed on the cardiovascular system are necessary for these devices. In tissue engineering and regenerative medicine, biomaterials are important. They can be used to build scaffolds that help new tissues like skin, bone, and cartilage grow. To deliver medications and other therapeutic agents to particular bodily parts, biomaterials can be used. They may be designed to discharge medications gradually, enabling targeted therapy. Dental implants, tooth replacement, and cavity filling all involve the use of biomaterials. Metals, ceramics, and polymers are just a few of the elements that can be used to create dental biomaterials.

India Biomaterials Healthcare Market Analysis

Market Dynamics

Market Growth Drivers

India's large and ageing population increases its susceptibility to serious illnesses including osteoarthritis and cardiovascular disease, which usually require the use of biomaterials as a therapy, leading to the growth of the country's biomaterial healthcare industry. The middle-class population in India has more disposable money, which is increasing the demand for advanced biomaterials. In recent years, the Indian government has increased its spending on healthcare, which is anticipated to lead to greater access to cutting-edge medical technologies, including biomaterials. Biomaterials-related technological developments, such as the creation of novel materials and production methods, are fueling industry innovation and expansion.

Market Restraints

Smaller biomaterials businesses in India may find it difficult to break into the healthcare biomaterials market due to the high cost of biomaterial development. The use of biomaterials in certain circumstances, such as stem cell research and tissue engineering, may be constrained by ethical concerns.

Competitive Landscape

Key Players

Poly Medicure (IN)
Sahajanand Medical Technologies (IN)
MicroPort
BASF SE
Celanese
Covestro AG
Evonik Industries

Notable Recent Deals

2021: Boston Scientific, a US-based manufacturer of medical devices, declared in 2021 that it had purchased the global embolic microspheres portfolio of BTG International, an Indian manufacturer of medical devices, which included several biomaterial-based goods.

2021: The University of Florida and the Indian pharmaceutical firm Sun Pharma entered into a licencing deal in 2021 for a novel biomaterial technology for ophthalmic use.

Healthcare Policies and Regulatory Landscape

The Indian Council of Medical Research (ICMR), the Central Drugs Standard Control Organization (CDSCO), and the National Health Systems Resource Centre (NHSRC) are the regulatory organisations in charge of regulating the biomaterial healthcare market in India. The CDSCO conducts a thorough review as part of the approval process for biomaterials in India. The evaluation of safety, efficacy, and quality are all part of the approval process for biomaterials, which are categorised as medical devices. In India, the cost of medical devices, including biomaterials, is governed by the National Pharmaceutical Pricing Authority (NPPA). The adoption and accessibility of biomaterials in the Indian market can be significantly impacted by pricing and reimbursement policies.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the India market in 2019. The growing geriatric population Indialy is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.